Selank vs Semax
Two Russian-developed nootropic peptides with complementary profiles—Selank excels at anxiolytic effects while Semax focuses on cognitive stimulation and neuroprotection.
Last updated: 2026-02-01
Selank and Semax are synthetic peptides developed by the Institute of Molecular Genetics at the Russian Academy of Sciences. Both are approved medications in Russia and have accumulated decades of clinical use and research, making them among the most well-studied nootropic peptides available.
**Selank** (TP-7) is a synthetic analogue of the immunomodulatory peptide tuftsin, combined with a stabilising sequence. It's primarily known for its anxiolytic (anti-anxiety) effects, often compared to benzodiazepines but without sedation or dependence risk. Selank is approved in Russia for generalised anxiety disorder and neurasthenia.
**Semax** is a synthetic analogue of ACTH (4-10), the fragment of adrenocorticotropic hormone responsible for cognitive effects without hormonal activity. It's approved in Russia for stroke recovery, cognitive enhancement, and optic nerve disorders. Semax is known for its stimulating, focus-enhancing properties.
**Important Note:** While both peptides have approved status in Russia, they are not approved by the MHRA, EMA, or FDA. This comparison is for educational purposes based on published research.
Quick Comparison Table
| Category | Selank | Semax |
|---|---|---|
| Origin | Tuftsin analogue + glyproline | ACTH (4-10) analogue |
| Approved Use (Russia) | Anxiety, neurasthenia | Stroke, cognitive disorders, optic nerve |
| Primary Effect | Anxiolytic (calming) | Nootropic (stimulating) |
| Mechanism Focus | GABAergic, serotonergic | BDNF, dopaminergic, NGF |
| Cognitive Profile | Subtle enhancement + calm | Strong focus + mental clarity |
| Administration | Intranasal drops | Intranasal drops |
| Half-Life | ~Several minutes (active metabolites longer) | ~Several minutes (active metabolites longer) |
| Onset of Effects | Minutes to hours | Minutes to hours |
| Amino Acids | 7 amino acids | 7 amino acids |
| Hormonal Effects | None | None (despite ACTH origin) |
| Dependency Risk | None reported | None reported |
| Best For | Anxiety, stress, social situations | Focus, learning, cognitive performance |
How They Work: Distinct Neurological Mechanisms
Selank
Selank Mechanism of Action:
Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro) is a heptapeptide combining tuftsin (an endogenous immunomodulatory peptide) with a glyproline stabilising sequence (Pro-Gly-Pro).
1. GABAergic Modulation Primary anxiolytic mechanism: - Enhances GABA neurotransmission - Allosteric modulation of GABA-A receptors - Similar mechanism to benzodiazepines - Does NOT cause sedation or dependence - No memory impairment (unlike benzos) - Maintains alertness while reducing anxiety
2. Serotonergic Effects Mood and anxiety regulation: - Modulates serotonin (5-HT) metabolism - Affects 5-HT1A and 5-HT2A receptors - May normalise serotonin turnover - Contributes to antidepressant-like effects - Stabilises emotional reactivity
3. Enkephalin System Endogenous opioid modulation: - Influences enkephalinase activity - Modulates endogenous opioid peptides - May contribute to anxiolytic effects - No euphoria or addiction potential - Subtle mood-stabilising properties
4. Immune Modulation From tuftsin heritage: - Normalises cytokine expression - IL-6 modulation observed - Potential stress-induced immunosuppression protection - May benefit chronic stress conditions
5. Gene Expression Effects Research has shown Selank affects expression of: - 84 genes in hippocampus - Genes related to neurotransmission - Genes involved in inflammation - Long-term neuroplasticity effects possible
Semax
Semax Mechanism of Action:
Semax (Met-Glu-His-Phe-Pro-Gly-Pro) is a heptapeptide based on ACTH (4-10), the cognitive-active fragment of adrenocorticotropic hormone, with a glyproline C-terminal extension for stability.
1. BDNF Upregulation Key neuroprotective mechanism: - Significantly increases Brain-Derived Neurotrophic Factor - BDNF promotes neuronal survival and growth - Enhances synaptic plasticity - Supports long-term potentiation (learning) - May promote neurogenesis - Central to cognitive enhancement effects
2. Dopaminergic Enhancement Focus and motivation: - Modulates dopamine and serotonin systems - Enhances dopamine signalling in prefrontal cortex - Improves attention and working memory - Contributes to motivational effects - May enhance reward sensitivity
3. NGF and Neurotrophin Cascade Neuroprotection: - Increases Nerve Growth Factor (NGF) - Stimulates other neurotrophins - Protects neurons from excitotoxicity - Used clinically in Russia for stroke recovery - Supports optic nerve regeneration
4. No Hormonal Activity Despite ACTH origin: - Does NOT affect cortisol levels - Does NOT stimulate adrenal glands - Purely cognitive/neurological effects - No endocrine side effects - Safe for long-term use
5. Melanocortin System Additional mechanisms: - Interacts with melanocortin receptors - MC3 and MC4 receptor modulation - May influence inflammation and appetite - Contributes to overall neuroprotective profile
6. Gene Expression Effects Semax has been shown to affect: - Over 1,000 genes in brain tissue - Immune-related gene expression - Vascular genes (relevant to stroke) - Broad transcriptomic effects
Clinical Trial Evidence
Selank Clinical Studies
Participants: 62 patients with generalised anxiety disorder
Duration: 14 days
Selank 0.15% nasal drops showed significant anxiolytic effects comparable to medazepam. Hamilton Anxiety Scale scores improved without sedation or cognitive impairment.
Key trial supporting Russian regulatory approval for GAD; established benzodiazepine-like efficacy without dependency
Participants: Animal model (hippocampal tissue)
Duration: Acute administration
Selank affected expression of 84 genes, including those involved in neurotransmission, inflammation, and apoptosis. GABA and serotonin pathway genes significantly modulated.
First demonstration of Selank's broad neurogenomic effects; mechanistic basis for anxiolytic and nootropic properties
Participants: 78 patients with neurasthenia
Duration: 21 days
Selank improved fatigue, anxiety, and cognitive symptoms. Significant improvements in attention and memory tests alongside anxiety reduction.
Supported expanded Russian indication; demonstrated dual anxiolytic and cognitive effects
Participants: 48 subjects with stress-related immune suppression
Duration: 14 days
Selank normalised IL-6 and other cytokine levels in stressed subjects. Immune function markers improved alongside anxiety reduction.
Established immunomodulatory properties; connected to tuftsin heritage
Participants: Russian pharmacovigilance data
Duration: 12+ years
No significant safety signals emerged during clinical use. No dependency, withdrawal, or serious adverse events reported at therapeutic doses.
Extensive real-world safety data supporting long-term tolerability
Semax Clinical Studies
Participants: 120 acute ischemic stroke patients
Duration: 10 days acute + 6 month follow-up
Semax 1% nasal drops significantly improved neurological recovery. Modified Rankin Scale and Barthel Index scores superior to control group at all timepoints.
Pivotal trial for Russian stroke indication; established neuroprotective clinical efficacy
Participants: 32 subjects (healthy volunteers + stroke patients)
Duration: 14 days
Semax administration significantly increased serum BDNF levels. Effect persisted throughout treatment and correlated with cognitive improvements.
Mechanistic validation of BDNF-mediated neuroprotection; supported cognitive enhancement claims
Participants: 86 patients with optic nerve disorders
Duration: 10-14 days
Semax improved visual acuity and visual field parameters in patients with optic nerve atrophy. Electrophysiological markers showed improved nerve function.
Led to Russian ophthalmological indication; demonstrated NGF-mediated nerve regeneration
Participants: 48 healthy adults
Duration: 7 days
Semax 1% improved attention, working memory, and verbal fluency on standardised cognitive testing. Effects peaked at day 5-7 of administration.
Established nootropic effects in healthy population; supported cognitive enhancement applications
Participants: 64 children with attention and learning difficulties
Duration: 21 days
Semax 0.1% improved attention span, memory, and school performance. Well-tolerated with no significant adverse events.
Extended paediatric data; supported use in developmental cognitive disorders
Benefits Comparison
Selank Unique Benefits
- Potent anxiolytic effects without sedation or cognitive impairment
- No dependency or withdrawal (unlike benzodiazepines)
- Subtle mood stabilisation and antidepressant-like effects
- Immunomodulatory properties may benefit stress-related immunity
- Improved stress resilience and emotional regulation
- Social anxiety reduction reported in research
Shared Benefits
- Well-tolerated with minimal side effects in research
- No reported dependency or addiction potential
- Both administered intranasally for CNS access
- Decades of clinical use and research in Russia
- Neuroprotective properties observed
- Both may have anti-inflammatory effects in the brain
- Stable peptides with glyproline C-terminus
Semax Unique Benefits
- Strong cognitive enhancement—focus, memory, learning
- Neuroprotective effects via BDNF and NGF upregulation
- Approved for stroke recovery in Russia with clinical evidence
- Mental clarity and stimulating effects without jitters
- May support optic nerve and visual function
- Potential antidepressant effects through dopamine modulation
Research & Evidence
Selank Research
Selank Research Summary:
Anxiety Disorder Clinical Trials Russian clinical studies: - Studied in generalised anxiety disorder patients - Comparable efficacy to benzodiazepines - No sedation, dependence, or withdrawal - Effects persist beyond treatment period - Led to Russian approval for anxiety and neurasthenia Multiple Russian clinical studies
Mechanism Studies Understanding how Selank works: - Demonstrated GABA-A receptor modulation - Shown to affect serotonin metabolism - Enkephalin system interaction confirmed - 84 genes affected in hippocampus (Kolomin et al.) Source: Various Russian Academy of Sciences publications
Immune Effects Research Immunomodulatory properties: - Tuftsin-derived immunomodulation retained - IL-6 and cytokine normalisation - Potential benefit in chronic stress - May protect against stress-induced immunosuppression
Cognitive Effects Secondary cognitive benefits: - Improved attention under stress - Enhanced memory consolidation - May work synergistically with Semax - Cognitive effects secondary to anxiolysis
Semax Research
Semax Research Summary:
Stroke and Brain Injury Studies Russian clinical evidence: - Approved for ischemic stroke in Russia - Improved recovery outcomes in trials - Neuroprotective when administered early - Reduced infarct size in animal models - Enhanced cognitive recovery post-stroke Source: Multiple Russian neurological journals
BDNF Research Core mechanism studies: - Significant BDNF upregulation demonstrated - Effects on NGF also confirmed - Neuroplasticity enhancement in animal models - Supports the "neurotrophic hypothesis" of benefits Source: Neuroscience research publications
Optic Nerve Studies Visual system applications: - Approved in Russia for optic nerve disorders - May support nerve regeneration - Used in glaucoma research - Potential for retinal protection
Cognitive Enhancement Studies Nootropic effects: - Improved attention and working memory - Enhanced learning in animal models - Gene expression studies show broad effects - Over 1,000 genes affected in transcriptomic studies
N-Acetyl-Semax and Semax Amidate Modified versions: - N-Acetyl-Semax: enhanced potency reported - Semax Amidate (NASA): further modifications - Community reports of increased effects - Less formal research on modifications
Head-to-Head Analysis
Selank vs Semax: Head-to-Head Considerations
While formal head-to-head clinical trials are limited, the research literature and clinical experience in Russia provide clear differentiation:
Primary Effect Comparison
| Aspect | Selank | Semax | |--------|--------|-------| | Anxiety Reduction | ++++ | + | | Cognitive Stimulation | + | ++++ | | Neuroprotection | ++ | ++++ | | Mood Stabilisation | +++ | ++ | | Focus/Attention | ++ | ++++ | | Stress Resilience | ++++ | ++ | | Energy/Alertness | ++ | +++ |
Complementary Rather Than Competing Key insight: - These peptides have different primary targets - Selank: anxiolytic, calming, stress-reducing - Semax: nootropic, stimulating, neuroprotective - Often used together in research - May provide balanced cognitive enhancement
Subjective Experience Comparison Based on research reports and anecdotal evidence: - Selank: "Calm focus," reduced social anxiety, emotional stability - Semax: "Sharp focus," mental clarity, motivation, stimulation - Combined: "Clear-headed confidence" often described
Time Course Differences Onset and duration: - Both have rapid onset (minutes via intranasal) - Semax effects may be more immediately noticeable - Selank effects can be subtle but cumulative - Both have short half-lives but effects persist - Active metabolites may extend duration
Protocol Comparison
Selank Protocol
Selank Theoretical Protocols:
⚠️ These are theoretical protocols derived from research literature for educational purposes only. Not medical advice.
Standard Research Protocol Common approach based on Russian approval: - Concentration: 0.15% solution (150 mcg/drop) - Dose: 200-400 mcg (1-3 drops per nostril) - Frequency: 2-3 times daily - Duration: 2-4 weeks typically studied - Administration: Intranasal
Acute Situational Use For specific anxiogenic situations: - Single dose 30-60 minutes before - 300-600 mcg typical range - Effects peak within 1-2 hours - Can be used as needed
Chronic Anxiety Protocols Extended use approach: - 200-300 mcg 2-3x daily - 14-21 day cycles studied - May cycle off periodically - Effects may persist after cessation
Practical Considerations: - Intranasal only (oral absorption poor) - Store refrigerated after reconstitution - No food timing requirements - Well-tolerated at various doses - Start lower to assess response
Semax Protocol
Semax Theoretical Protocols:
⚠️ These are theoretical protocols derived from research literature for educational purposes only. Not medical advice.
Standard Research Protocol Based on Russian clinical use: - Concentration: 0.1% or 1% solution - Dose: 200-600 mcg per administration - Frequency: 2-3 times daily - Duration: 10-14 days typical cycle - Administration: Intranasal
Cognitive Enhancement Protocol For focus and learning: - 300-600 mcg morning dose - Optional mid-day dose - Avoid late evening (stimulating) - 2-4 week cycles
Neuroprotection/Recovery Protocol Higher dose approach (research-based): - Up to 1000+ mcg daily in some studies - Divided doses throughout day - Clinical supervision recommended - Used in stroke recovery in Russia
Modified Versions: - N-Acetyl-Semax: May be 50-100x more potent - Semax Amidate: Further enhanced version - Lower doses needed for modified forms - Less formal dosing data available
Practical Considerations: - Intranasal administration optimal - Morning/daytime dosing preferred - May cause stimulation if taken late - Refrigerate reconstituted solution - Effects noticeable same day
Combined Use
Selank + Semax Combination:
⚠️ Theoretical protocol for educational purposes only.
Why Combine Both Peptides? Complementary effects: - Selank provides anxiolysis and calm - Semax provides focus and cognitive drive - Combined: "calm confidence" with mental clarity - Balances stimulation with relaxation - Popular combination in nootropic research
Common Combination Protocol Balanced approach: - Selank: 200-300 mcg 2x daily - Semax: 200-400 mcg 1-2x daily - Can be administered together or separately - Same intranasal route for both - Morning and mid-day timing typical
Stacking Strategy Timing considerations:
| Time | Selank | Semax | |------|--------|-------| | Morning | 200 mcg | 300 mcg | | Midday | Optional | 200 mcg (optional) | | Evening | 200 mcg | Avoid (stimulating) |
Synergy Considerations: - Both share glyproline C-terminus - Different primary mechanisms - Unlikely to compete for receptors - May enhance each other's benefits - Selank may offset any Semax-induced anxiety
Duration for Combined Use: - 2-4 week cycles commonly used - May alternate which is primary - Some use continuously at lower doses - Periodic breaks recommended - Monitor individual response
Safety Profiles
Selank Safety
Selank Safety Profile:
Common Side Effects: - Fatigue or drowsiness (uncommon, usually mild) - Nasal irritation from administration - Mild headache (rare) - Unusual taste after nasal administration - Generally very well tolerated
Rare/Theoretical Risks: - Allergic reactions (rare with any peptide) - Unknown long-term effects outside Russia - Limited data on drug interactions - Potential effects on immune function (theoretical)
What Makes Selank Safe: - No sedation (unlike benzodiazepines) - No dependence or withdrawal syndrome - No cognitive impairment - No memory problems - No respiratory depression - Decades of clinical use in Russia
Contraindications: - Known peptide allergies - Pregnancy and breastfeeding (insufficient data) - Children (limited paediatric data) - Active infections (theoretical immune concern)
Drug Interactions: - May potentiate other anxiolytics - Generally safe with most medications - Limited formal interaction studies - Consult healthcare provider if on medications
Long-Term Considerations: - Russian approval suggests acceptable safety - Used chronically by some - Effects may persist after cessation - Cycling recommended as precaution
Semax Safety
Semax Safety Profile:
Common Side Effects: - Nasal irritation or discomfort - Mild headache (uncommon) - Overstimulation if dose too high - Difficulty sleeping if taken late - Hair growth reported anecdotally (unusual)
Rare/Theoretical Risks: - Allergic reactions possible - Unknown long-term effects outside Russia - Theoretical concern with melanocortin modulation - Limited Western clinical data
What Makes Semax Safe: - No hormonal effects despite ACTH origin - Does not affect cortisol or adrenals - No dependency or withdrawal - No cardiovascular stimulation - Decades of use in Russia - Approved for serious conditions (stroke)
Contraindications: - Known peptide allergies - Pregnancy and breastfeeding (insufficient data) - Children (limited data, though studied) - History of seizures (theoretical caution) - Acute psychosis (stimulating effects)
Drug Interactions: - May interact with dopaminergic medications - Caution with stimulants (additive effects) - Limited formal interaction data - Consult healthcare provider
N-Acetyl-Semax Considerations: - Much more potent—lower doses needed - Higher risk of overstimulation - Less safety data available - Start very low with modified versions
The Verdict: When to Choose Which?
Choose Selank When:
- Primary concern is anxiety or stress reduction
- Social anxiety or performance anxiety situations
- Need calm focus without stimulation
- Seeking benzodiazepine alternative without dependency
- Stress-related sleep difficulties (not from stimulant)
- Want subtle cognitive support with emotional stability
Choose Semax When:
- Primary goal is cognitive enhancement and focus
- Need mental clarity and stimulation for demanding tasks
- Research interest in neuroprotection (stroke, brain injury)
- Want noticeable, immediate cognitive effects
- Memory and learning enhancement is the priority
- Creative or analytical work requiring mental sharpness
Consider Combining When:
- Want balanced effects—calm confidence with mental clarity
- Need to reduce anxiety while maintaining sharp focus
- Comprehensive nootropic stack for cognitive optimization
- High-stress cognitive performance situations
- Seeking anxiolysis without mental dulling
- Research into synergistic peptide combinations
- Many experienced users prefer the combination
Frequently Asked Questions
Conclusion
## Conclusion: Selank vs Semax
Selank and Semax represent two complementary approaches to cognitive and emotional optimization, developed through decades of research at the Russian Academy of Sciences. Their different primary mechanisms make them suitable for different needs—and powerful when combined.
Selank excels as a modern anxiolytic that offers the stress-reducing benefits of benzodiazepines without sedation, dependence, or cognitive impairment. Working through GABAergic and serotonergic pathways, it provides calm focus and emotional stability. For those dealing with anxiety, social stress, or seeking enhanced stress resilience, Selank is the natural choice.
Semax stands out as a potent nootropic with strong neuroprotective properties. Through BDNF upregulation and dopaminergic enhancement, it delivers noticeable improvements in focus, memory, and mental clarity. Its approval for stroke recovery in Russia speaks to its genuine neurological effects. For cognitive performance, learning enhancement, or neuroprotection, Semax is the clear option.
Together, these peptides offer a balanced approach that many researchers consider superior to either alone. Selank's calming effects offset any potential anxiety from Semax's stimulation, while Semax's cognitive drive prevents any dulling from anxiolysis. The result is often described as "confident clarity"—sharp mental performance without stress or anxiety.
Key considerations for researchers: - Both are administered intranasally for direct CNS access - Both have decades of Russian clinical use supporting safety - Neither causes dependency or significant side effects - Both remain unapproved in Western regulatory frameworks - Quality sourcing is essential for any research
The choice between Selank and Semax—or the decision to combine them—depends on individual research goals. For pure anxiety focus, Selank. For pure cognitive enhancement, Semax. For comprehensive nootropic research, the combination remains a gold standard approach.
*Always consult accredited suppliers and qualified healthcare professionals in your jurisdiction.*
Medical Disclaimer
The information provided in this comparison is for educational and research purposes only. Neither Selank nor Semax is approved for human therapeutic use by the MHRA, EMA, or FDA. This content does not constitute medical advice. Always consult a qualified healthcare professional before considering any peptide or supplement.